CRYO-CELL INTL INC (CCEL) Fundamental Analysis & Valuation
NYSEARCA:CCEL • US2288951088
Current stock price
3.67 USD
-0.24 (-6.13%)
At close:
3.48 USD
-0.19 (-5.18%)
After Hours:
This CCEL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CCEL Profitability Analysis
1.1 Basic Checks
- CCEL had negative earnings in the past year.
- In the past year CCEL had a positive cash flow from operations.
- In multiple years CCEL reported negative net income over the last 5 years.
- In the past 5 years CCEL always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of CCEL (-0.75%) is comparable to the rest of the industry.
- CCEL's Return On Invested Capital of 7.64% is fine compared to the rest of the industry. CCEL outperforms 73.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CCEL is in line with the industry average of 8.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROIC | 7.64% |
ROA(3y)-6.29%
ROA(5y)-2.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.32%
ROIC(5y)8.46%
1.3 Margins
- Looking at the Operating Margin, with a value of 13.63%, CCEL belongs to the top of the industry, outperforming 86.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of CCEL has declined.
- CCEL has a Gross Margin of 77.07%. This is amongst the best in the industry. CCEL outperforms 92.00% of its industry peers.
- In the last couple of years the Gross Margin of CCEL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% |
OM growth 3Y4.95%
OM growth 5Y-11.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.57%
GM growth 5Y2.12%
2. CCEL Health Analysis
2.1 Basic Checks
- CCEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- CCEL has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, CCEL has more shares outstanding
- The debt/assets ratio for CCEL is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.07, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
- CCEL has a worse Altman-Z score (0.07) than 75.00% of its industry peers.
- CCEL has a debt to FCF ratio of 1.36. This is a very positive value and a sign of high solvency as it would only need 1.36 years to pay back of all of its debts.
- The Debt to FCF ratio of CCEL (1.36) is better than 82.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Altman-Z | 0.07 |
ROIC/WACC0.64
WACC11.98%
2.3 Liquidity
- A Current Ratio of 0.63 indicates that CCEL may have some problems paying its short term obligations.
- CCEL has a worse Current ratio (0.63) than 87.00% of its industry peers.
- CCEL has a Quick Ratio of 0.63. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.60, CCEL is doing worse than 84.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 |
3. CCEL Growth Analysis
3.1 Past
- The earnings per share for CCEL have decreased strongly by -1750.00% in the last year.
- The Revenue has decreased by -1.31% in the past year.
- The Revenue has been growing slightly by 0.27% on average over the past years.
EPS 1Y (TTM)-1750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.33%
Revenue growth 5Y0.27%
Sales Q2Q%-3.59%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y123.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CCEL Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CCEL. In the last year negative earnings were reported.
- With a Price/Forward Earnings ratio of 51.40, CCEL can be considered very expensive at the moment.
- CCEL's Price/Forward Earnings ratio is in line with the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 22.24. CCEL is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 51.4 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CCEL is valued cheaply inside the industry as 89.00% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, CCEL is valued cheaply inside the industry as 96.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.78 | ||
| EV/EBITDA | 6.34 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CCEL Dividend Analysis
5.1 Amount
- CCEL has a Yearly Dividend Yield of 11.17%, which is a nice return.
- Compared to an average industry Dividend Yield of 0.47, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, CCEL pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.17% |
5.2 History
- CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- The earnings of CCEL are negative and hence is the payout ratio. CCEL will probably not be able to sustain this dividend level.
DP-1109.12%
EPS Next 2YN/A
EPS Next 3YN/A
CCEL Fundamentals: All Metrics, Ratios and Statistics
3.67
-0.24 (-6.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)04-14 2026-04-14/amc
Earnings (Next)07-13 2026-07-13
Inst Owners12.47%
Inst Owner Change-41.71%
Ins Owners41.98%
Ins Owner Change0.79%
Market Cap29.58M
Revenue(TTM)31.57M
Net Income(TTM)-473.50K
Analysts43.33
Price Target8.67 (136.24%)
Short Float %0.26%
Short Ratio0.78
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.17% |
Yearly Dividend0.4
Dividend Growth(5Y)N/A
DP-1109.12%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)227.45%
Min EPS beat(2)178.43%
Max EPS beat(2)276.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.61%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-3.33%
Revenue beat(4)0
Avg Revenue beat(4)-2.41%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-2.16%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)116.67%
EPS NY rev (3m)116.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.39%
Revenue NY rev (3m)1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 51.4 | ||
| P/S | 0.93 | ||
| P/FCF | 4.78 | ||
| P/OCF | 4.65 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.34 |
EPS(TTM)-0.33
EYN/A
EPS(NY)0.07
Fwd EY1.95%
FCF(TTM)0.77
FCFY20.9%
OCF(TTM)0.79
OCFY21.48%
SpS3.94
BVpS-1.84
TBVpS-2.19
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | N/A | ||
| ROCE | 9.68% | ||
| ROIC | 7.64% | ||
| ROICexc | 8.24% | ||
| ROICexgc | 8.84% | ||
| OM | 13.63% | ||
| PM (TTM) | N/A | ||
| GM | 77.07% | ||
| FCFM | 19.48% |
ROA(3y)-6.29%
ROA(5y)-2.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.32%
ROIC(5y)8.46%
ROICexc(3y)8.86%
ROICexc(5y)9.39%
ROICexgc(3y)9.56%
ROICexgc(5y)10.26%
ROCE(3y)10.53%
ROCE(5y)10.71%
ROICexgc growth 3Y10.58%
ROICexgc growth 5Y-24.53%
ROICexc growth 3Y10.79%
ROICexc growth 5Y-22.99%
OM growth 3Y4.95%
OM growth 5Y-11.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.57%
GM growth 5Y2.12%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.36 | ||
| Debt/EBITDA | 1.54 | ||
| Cap/Depr | 17.31% | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 119.5% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 0.07 |
F-Score7
WACC11.98%
ROIC/WACC0.64
Cap/Depr(3y)286.14%
Cap/Depr(5y)369.56%
Cap/Sales(3y)10.02%
Cap/Sales(5y)15.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1750%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y123.03%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.31%
Revenue growth 3Y1.33%
Revenue growth 5Y0.27%
Sales Q2Q%-3.59%
Revenue Next Year-3.55%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.52%
EBIT growth 3Y6.35%
EBIT growth 5Y-11.56%
EBIT Next Year1.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.23%
FCF growth 3YN/A
FCF growth 5Y-8.91%
OCF growth 1Y-11.72%
OCF growth 3Y-13.86%
OCF growth 5Y-8.34%
CRYO-CELL INTL INC / CCEL Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for CRYO-CELL INTL INC?
ChartMill assigns a fundamental rating of 3 / 10 to CCEL.
What is the valuation status of CRYO-CELL INTL INC (CCEL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CRYO-CELL INTL INC (CCEL). This can be considered as Fairly Valued.
What is the profitability of CCEL stock?
CRYO-CELL INTL INC (CCEL) has a profitability rating of 4 / 10.
Can you provide the financial health for CCEL stock?
The financial health rating of CRYO-CELL INTL INC (CCEL) is 3 / 10.